Publicaciones en las que colabora con Jesus Oteo Iglesias (8)

2017

  1. Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3283-3287

2016

  1. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

2013

  1. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 2, pp. 317-321

2010

  1. AmpC β-lactamases in Escherichia coli: Emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131

    Diagnostic Microbiology and Infectious Disease, Vol. 67, Núm. 3, pp. 270-276

2009

  1. Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycoside-modifying enzyme gene ant(4′)-Ia and the efflux pump genes msrA/msrB

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 1, pp. 21-31

2008

  1. Emergence of imipenem resistance in clinical Escherichia coli during therapy

    International Journal of Antimicrobial Agents, Vol. 32, Núm. 6, pp. 534-537

  2. Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain

    Emerging Infectious Diseases, Vol. 14, Núm. 8, pp. 1259-1262

2006

  1. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions

    Journal of Clinical Microbiology, Vol. 44, Núm. 7, pp. 2359-2366